시장보고서

상품코드

1532834

면역치료제 시장 : 유형별, 제품별, 유통별, 투여 경로별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Immunotherapy Drugs Market, By Type, By Product, By Distribution, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 07월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 381 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

면역치료제 시장 규모는 2023년 2,788억 9,778만 달러로 2024년부터 2032년까지 연평균 14.92%의 성장률을 보일 것으로 예상됩니다.

면역치료제 시장 - 시장 역학

전 세계 암 환자 수 증가

암 발병률의 증가로 인해 효과적인 치료법에 대한 수요가 증가함에 따라 암과 싸우기 위해 신체의 면역 체계를 활용하는 면역요법이 보편적인 선택이 되고 있으며, 이는 이러한 약물의 시장 확대로 이어지고 있습니다. 보다 효과적인 새로운 치료법에 대한 필요성은 연구개발(R&D)에 대한 투자에 박차를 가하고 있습니다. 여기에는 임상시험을 위한 자금 조달, 새로운 면역치료 접근법 모색, 신약 개발 등이 포함됩니다. 기업들은 증가하는 수요에 대응하기 위해 제품 포트폴리오를 확장하고 새로운 시장에 진출하고 있습니다. 여기에는 다양한 유형의 암에 대한 치료법 개발, 면역치료의 효과를 높이기 위한 병용요법 개발 등이 포함됩니다. 예를 들어, 런던에 위치한 암연구소(The Institute of Cancer Research, London)의 연구진은 저분자 면역종양학 기업인 네오포어(NeoPhore)와 협력하여 새로운 잠재적 암 치료제를 개발하기 위해 네오항원을 발굴하고 있습니다. 크리스 로드 교수가 이끄는 ICR 팀은 새로운 전략적 연구 협력의 일환으로 NeoPhore의 억제제가 실험실에서 종양에 어떤 영향을 미치는지 조사할 예정입니다.

면역치료제 시장 - 주요 인사이트

당사의 리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 연평균 약 14.92%의 CAGR로 성장할 것으로 예상됩니다.

시장 세분화에서는 2023년 단클론항체가 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

제품 유형별로는 2023년 생물학적 제제가 주요 유형이었습니다.

유통 부문별로는 2023년 소매 약국이 주요 유형으로 나타났습니다.

최종사용자 세분화에서는 2023년 병원이 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출 1위

면역치료제 시장 - 세분화 분석:

면역치료제 세계 시장은 유형, 제품, 유통, 투여 경로, 최종사용자 및 지역에 따라 세분화됩니다.

제품은 유형에 따라 6가지로 분류됩니다: 단클론항체, 백신, 체크포인트 억제제, 비특이적 면역요법, 암세포 바이러스 면역요법, T세포 요법입니다. mAbs는 암세포, 병원체, 염증 세포 표면의 단백질과 같은 특정 항원에 특이적으로 결합하도록 설계되었습니다. 이러한 표적화는 건강한 세포와 조직에 대한 손상을 최소화하여 치료 효과를 높이고 부작용을 줄입니다. 또한 치료에 높은 특이성을 가져와 질병의 정확한 진단과 치료에 도움이 될 수 있습니다.

시장은 용도에 따라 병원, 진료소, 암 연구 센터, 외래 수술 센터, 재택 의료 현장 등 5가지 범주로 나뉩니다. 면역치료제는 암세포를 인식하고 파괴하는 신체의 자연 면역체계의 능력을 강화하거나 회복하도록 설계되었습니다. 이 표적화된 접근법은 화학요법이나 방사선 치료와 같은 기존 치료법에 비해 더 효과적이고 건강한 세포에 대한 손상이 적습니다. 면역치료는 암의 특성에 따라 환자 개개인에게 맞춤화할 수 있습니다. 이러한 개별화된 접근 방식은 치료 결과를 개선하고 부작용을 줄일 수 있습니다.

면역치료제 시장 - 지리적 인사이트

면역치료제 시장은 제약 업계에서 빠르게 성장하고 있는 분야로, 북미 각 지역에서 활발한 활동과 시장 개척이 이루어지고 있습니다. 미국은 선진적인 의료 인프라, 풍부한 R&D 투자, 높은 암 발병률, FDA의 다수의 면역치료제 승인, 생명공학 기업 및 제약기업의 강력한 입지가 성장을 주도하고 있으며, 독일, 프랑스, 영국 등은 강력한 헬스케어 시스템과 활발한 시장 개척을 통해 면역치료제 시장을 주도하고 있습니다. 독일, 프랑스, 영국 등은 강력한 의료 시스템과 활발한 연구 기관으로 인해 면역치료제 시장에서 두각을 나타내고 있습니다. 유럽의약품청(EMA)은 의약품 승인과 시장 진입에 있어 중요한 역할을 하고 있습니다. 또한, 인도는 암 발병률 증가와 헬스케어 인프라 구축으로 면역치료에 대한 관심이 높아지고 있는 신흥 시장으로, 2023년 10월 미국 식품의약국(FDA)에 해당하는 인도의 중앙의약품표준관리기구(Central Drugs Standard Control Organization)가 설립될 예정입니다. Organization)은 NexCAR19를 인도 최초의 CAR-T 세포 치료제로 승인했습니다.

면역치료제 시장 - 경쟁 구도:

면역치료제 시장의 주요 기업 브리스톨마이어스스퀴브, 머크, 로슈, 화이자, 노바티스, 암젠 등이 있습니다. 면역치료제 시장은 매우 다양하며, 여러 주요 기업들이 단클론항체, 체크포인트 억제제, CAR-T 세포 치료제, 기타 혁신치료제 등 다양한 분야에 진출해 있습니다. 머크는 PD-1/PD-L1 억제제 시장의 선두주자로서 풍부한 임상 데이터와 광범위한 적응증을 보유하고 있습니다. 화이자(Pfizer)는 면역치료와 표적치료 모두에 정통하고 강력한 임상연구를 진행하고 있으며, 2024년 2월 플로리다대학교 보건암센터 연구팀은 다양한 종류의 암 치료에 면역치료의 새로운 길을 열어줄 수 있는 세계 최초의 화합물을 개발했습니다. 또한, 캘리포니아주 사우전드오크스와 뉴저지주 케닐워스는 비호지킨림프종(NHL) 중 가장 흔한 유형인 미만성 거대 B세포 림프종(DLBCL) 환자를 대상으로 BLINCYTO와 KEYTRUDA의 병용요법을 검토하는 1b/3상 임상시험을 진행 중입니다. 를 지원하는 암 면역치료 공동연구를 발표했습니다. 이 시장은 빠른 기술 혁신이 특징이며, 병용요법, 맞춤치료 등 보다 효과적인 새로운 치료법을 개발하는 데 중점을 두고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 면역치료제 업계

경쟁 대시보드
기업 개요
- Bristol-Myers Squibb
- Merck &Co.
- Roche
- Pfizer
- Novartis
- Gilead Sciences
- Amgen
- Sanofi
- Regeneron Pharmaceuticals
- Bluebird Bio
- Cellectis
- Others

제14장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Immunotherapy Drugs Market size was valued at USD 278,897.78 million in 2023, expanding at a CAGR of 14.92% from 2024 to 2032.

The rising number of cancer cases worldwide is a major driver for the growth of immunotherapy drugs. Immunotherapies offer new hope for patients with various types of cancer. Continuous R&D in immunotherapy has led to the development of more effective and targeted therapies, including checkpoint inhibitors, CAR-T cell therapies, and monoclonal antibodies. However, some immunotherapies can cause severe side effects, such as cytokine release syndrome or autoimmune reactions, which need careful management. The production of some immunotherapy drugs, like CAR-T cell therapies, involves complex and costly manufacturing processes. Furthermore, strategic collaborations between pharmaceutical companies, research institutions, and biotech firms can accelerate the development of new therapies and expand market reach.

Immunotherapy Drugs Market- Market Dynamics

The increasing number of cancer cases worldwide

The growing incidence of cancer drives demand for effective treatments. Immunotherapy, which harnesses the body's immune system to fight cancer, is becoming a popular choice, leading to an increased market for these drugs. The need for new and more effective treatments spurs investment in research and development (R&D). This includes funding for clinical trials, exploring new immunotherapy approaches, and developing novel drugs. Companies are expanding their product portfolios and entering new markets to meet the growing demand. This includes developing therapies for different types of cancer and creating combination treatments that enhance the effectiveness of immunotherapies. For instance, To create novel, potentially effective cancer medications, researchers at The Institute of Cancer Research, London, are collaborating with NeoPhore, a small molecule immuno-oncology business, to identify neoantigens. An ICR team under the direction of Professor Chris Lord will examine how NeoPhore's inhibitors affect tumors in the lab as part of a new strategic research cooperation.

Immunotherapy Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.92% over the forecast period (2024-2032)

Based on type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on product segmentation, Biologics was the leading type in 2023

Based on distribution segmentation, Retail Pharmacies was the leading type in 2023

Based on end-user segmentation, Hospitals was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Immunotherapy Drugs Market- Segmentation Analysis:

The Global Immunotherapy Drugs Market is segmented based on Type, Product, Distribution, Route of Administration, End User, and Region.

The market is divided into six categories based on product type: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Non-Specific Immunotherapies, Oncolytic Virus Immunotherapy, and T-Cell Therapy. mAbs are designed to bind specifically to certain antigens, such as proteins on the surface of cancer cells, pathogens, or inflammatory cells. This targeting minimizes damage to healthy cells and tissues, making treatments more effective and reducing side effects. They provide high specificity in treatment, which helps in accurately diagnosing and treating diseases.

The market is divided into five categories based on application: Hospitals, Clinics, Cancer Research Centers, Ambulatory Surgical Centers, and Homecare Settings. Immunotherapy drugs are designed to enhance or restore the body's natural immune system's ability to recognize and destroy cancer cells. This targeted approach can be more effective and less damaging to healthy cells compared to traditional treatments like chemotherapy and radiation. Immunotherapy can be tailored to individual patients based on the specific characteristics of their cancer. This personalized approach can improve treatment outcomes and reduce side effects.

Immunotherapy Drugs Market- Geographical Insights

The immunotherapy drugs market is a rapidly growing sector in the pharmaceutical industry, with significant activity and development occurring across North American regions. The U.S. is a major player in the immunotherapy market due to its advanced healthcare infrastructure, substantial R&D investments, and high prevalence of cancer. The FDA's approval of numerous immunotherapy drugs and the strong presence of biotech and pharmaceutical companies drive growth. Countries like Germany, France, and the UK are prominent in the immunotherapy market due to their strong healthcare systems and active research institutions. The European Medicines Agency (EMA) plays a crucial role in drug approvals and market access. Furthermore, India is an emerging market with growing interest in immunotherapy, driven by increasing cancer incidence and improving healthcare infrastructure. In October 2023, India's counterpart to the US Food and Drug Administration, the Central Drugs Standard Control Organization, made NexCAR19 India's first approved CAR-T cell therapy.

Immunotherapy Drugs Market- Competitive Landscape:

Leading players in the immunotherapy drugs market Bristol-Myers Squibb, Merck & Co., Roche, Pfizer, Novartis, and Amgen, etc. The immunotherapy drugs market is diverse and includes several key players across various segments, including monoclonal antibodies, checkpoint inhibitors, CAR-T cell therapies, and other innovative treatments. Merck & Co. is a market leader in PD-1/PD-L1 inhibitors, with extensive clinical trial data, and broad indications. Pfizer has expertise in both immunotherapy and targeted therapies and strong clinical research. In February 2024, A team of UF Health Cancer Center researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer. In addition, THOUSAND OAKS, Calif. and KENILWORTH, N.J., announced a cancer immunotherapy collaboration to support a Phase 1b/3 study investigating BLINCYTO in combination with KEYTRUDA in patients with diffuse large B-cell lymphoma (DLBCL), which is the most common type of non-Hodgkin lymphoma (NHL). The market is characterized by rapid innovation, with a focus on developing new and more effective therapies, including combination therapies and personalized treatments.

Recent Developments:

In April 2024, BostonGene and Saga University announced the launch of a collaboration aimed at discovering biomarkers for immunotherapy (IO) treatment response and treatment-related toxicity in advanced non-small cell lung cancer (NSCLC) patients. EGFR-TKI treatment effectively targets EGFR mutation-positive NSCLC. Still, acquired resistance often leads to recurrence within 1 to 2 years, presenting a challenge for post-treatment optimization.

In June 2022, The Mark Foundation for Cancer Research expanded its partnership with the Johns Hopkins University to accelerate groundbreaking immunotherapy research. The collaboration with the Bloomberg~Kimmel Institute allows us to develop the next-generation genomics and imaging platforms for cancer immunotherapy necessary to save lives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTHERAPY DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bristol-Myers Squibb

Merck & Co.

Roche

Pfizer

Novartis

Gilead Sciences

Amgen

Sanofi

Regeneron Pharmaceuticals

Bluebird Bio

Cellectis

Others

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapies
Oncolytic Virus Immunotherapy
T-Cell Therapy

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

Biologics
Recombinant Proteins
Antibodies
Small Molecules

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Intravenous (IV)
Subcutaneous
Oral
Intramuscular

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Clinics
Cancer Research Centers
Ambulatory Surgical Centers
Homecare Settings

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Immunotherapy Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Immunotherapy Drugs Market Snippet by Type
- 2.1.2. Immunotherapy Drugs Market Snippet by Product
- 2.1.3. Immunotherapy Drugs Market Snippet by Distribution
- 2.1.4. Immunotherapy Drugs Market Snippet by Route of Administration
- 2.1.5. Immunotherapy Drugs Market Snippet by End User
- 2.1.6. Immunotherapy Drugs Market Snippet by Country
- 2.1.7. Immunotherapy Drugs Market Snippet by Region
2.2. Competitive Insights

3. Immunotherapy Drugs Key Market Trends

3.1. Immunotherapy Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Immunotherapy Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Immunotherapy Drugs Market Opportunities
3.4. Immunotherapy Drugs Market Future Trends

4. Immunotherapy Drugs Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Immunotherapy Drugs Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Immunotherapy Drugs Market Landscape

6.1. Immunotherapy Drugs Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Immunotherapy Drugs Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Vaccines
- 7.1.4. Checkpoint Inhibitors
- 7.1.5. Non-Specific Immunotherapies
- 7.1.6. Oncolytic Virus Immunotherapy
- 7.1.7. T-Cell Therapy

8. Immunotherapy Drugs Market - By Product

8.1. Overview
- 8.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 8.1.2. Biologics
  - 8.1.2.1. Recombinant Proteins
  - 8.1.2.2. Antibodies
- 8.1.3. Small Molecules

9. Immunotherapy Drugs Market - By Distribution

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies

10. Immunotherapy Drugs Market - By Route of Administration

10.1. Overview
- 10.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 10.1.2. Intravenous (IV)
- 10.1.3. Subcutaneous
- 10.1.4. Oral
- 10.1.5. Intramuscular

11. Immunotherapy Drugs Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Clinics
- 11.1.4. Cancer Research Centers
- 11.1.5. Ambulatory Surgical Centers
- 11.1.6. Homecare Settings

12. Immunotherapy Drugs Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Immunotherapy Drugs Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Immunotherapy Drugs Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Immunotherapy Drugs Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Immunotherapy Drugs Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Immunotherapy Drugs Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Immunotherapy Drugs Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Bristol-Myers Squibb
- 13.2.2. Merck & Co.
- 13.2.3. Roche
- 13.2.4. Pfizer
- 13.2.5. Novartis
- 13.2.6. Gilead Sciences
- 13.2.7. Amgen
- 13.2.8. Sanofi
- 13.2.9. Regeneron Pharmaceuticals
- 13.2.10. Bluebird Bio
- 13.2.11. Cellectis
- 13.2.12. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us